Cited by 21Endometriosis Research and TreatmentOvarian cancer diagnosis and treatmentGynecological conditions and treatments

The value of urocortin and Ca-125 in the diagnosis of endometrioma

Tokmak, Aytekin, Ugur, Mustafa, Tonguc, Esra, Var, Turgut, Moraloğlu, Ozlem, Ozaksit, Gülnur·2011·Archives of Gynecology and Obstetrics

Abstract

Purposes In this study, we sought to establish the value of a new molecule, urocortin (Ucn), in the diagnosis of endometrioma and compare with Ca-125 to identify superiority of urocortin.Methods Of the patients operated on at our hospital with the initial diagnosis of adnexal mass, 88 patients whose pathology results were endometrioma and benign ovarian cyst were included in the study. As a result of the pathological examination, the patients were assessed in two groups. Group 1 consisted of 42 cases of endometrioma and Group 2 included 46 cases of benign ovarian cyst (control group). The serum Ucn and CA 125 levels of patients were measured from the blood samples drawn prior to the operation.Results While the serum Ucn level was 4.8 ± 1.00 ng/ml in the endometrioma group, it was 4.5 ± 1.03 ng/ml in the control group (P = 0.21). The difference was statistically not meaningful. On the other hand, mean serum Ca-125 level was 43.8 U/l (11.7-251) in the endometrioma group, it was 16.5 U/l (4.3-121.1) in the control group. The difference was statistically meaningful (P = 0.001). When the cut-off point for Serum Ca-125 level was taken as 21.38, sensitivity and specificity levels were found to be 88.1 and 63%. When the cut-off point for Ucn was taken as 4.16, sensitivity was 76.2%, and specificity 45.7%.Conclusion Ucn was not found to be efficient in distinguishing endometrioma from other benign ovarian cysts or to be superior to CA125 in the diagnosis of endometrioma.

Integrity signals

Registry

Crossref · 10.1007/s00404-010-1505-2

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combinations of CA-125 with urocortin, chlamydia antibody, CD23, and inflammatory cytokines did not provide sufficiently high sensitivity or specificity for endometriosis and results remained unvalidated.

    “CA-125 has been measured simultaneously with urocortin [34], chlamydia antibody [35], CD23 [39], and inflammatory cytokines [32]. However, none of these combinations provided a sufficiently high sensitivity or specificity for endometriosis and results remained unvalidated.”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [34]

Cites

Flagged first, then by citations

1 of the 21 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Tokmak, A., Ugur, M., Tonguc, E., Var, T., Moraloğlu, O., & Ozaksit, G.
Affiliations
Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi (TR)
Corresponding author
Tonguc, Esra
Venue
Archives of Gynecology and Obstetrics
Published
2010-05-18
Volume
283
Issue
5
Pages
1075-1079
ISSN
  • 0003-9128 (ISSN-L)
  • 0932-0067
  • 1432-0711
OpenAlex
W2041670026
Cited by
21
References
21
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 1
FWCI
0.76
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Gynecology and Obstetrics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
urocortin, CA125, endometrioma, benign ovarian cysts, adnexal mass, serum biomarkers, sensitivity and specificity, differential diagnosis
MeSH terms
Adult, Endometriosis, Female, Humans, Middle Aged, ROC Curve, CA-125 Antigen, Urocortins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review